Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More Topics Petrovax Pharm
02.06.2020
The Three Volcanoes Park LLC  will build a world-class tourism cluster in the area of Vilyuchinsky, Mutnovsky and Gorely volcanoes, with access to Vilyuchinsky Bay.
More Topics "Three Volcanoes" Park
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm
23.03.2020
The Foundation is now announcing the launch of new large-scale initiatives to help non-profits and their beneficiaries to survive the next few months
More Topics COVID-19 / donations / coronavirus / Vladimir Potanin
25.10.2019
The common take-away was that «to become nature lovers, people need to have access to nature». Thus, the number one task is to create a legislative framework, currently all but non-existent.
More Topics Interros / Sustainable tourism / ecotourism / nature tourism / Rosa Khutor